Share this article Share this article ResearchAndMarkets.com's offering. Global Hemoglobin A1C Monitoring Market to Reach $1.7 Billion by 2027 Amid the COVID-19 crisis, the global market for Hemoglobin A1C Monitoring estimated at US$1 Billion in the year 2020, is projected to reach a revised size of US$1.7 Billion by 2027, growing at a CAGR of 7.8% over the analysis period 2020-2027. Ion-Exchange High Performance Liquid Chromatography (HPLC), one of the segments analyzed in the report, is projected to record a 8.8% CAGR and reach US$734.8 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Immunoassays segment is readjusted to a revised 7.6% CAGR for the next 7-year period.